Dialysis News and Research

Latest Dialysis News and Research

DaVita introduces Kidney Smart website for patients with CKD

DaVita Inc., a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the launch of its Kidney Smart website, for anyone with questions about CKD.

10 Apr 2012

FDA selects three renal device projects for new Pathway program

A UCSF-led effort to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the Food and Drug Administration.

10 Apr 2012

FDA approval of OMONTYS triggers $50M milestone payment to Affymax

Affymax, Inc. today announced that it has received a $50 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize OMONTYS (peginesatide) Injection.

10 Apr 2012

Three ESRD products chosen for FDA's Innovation Pathway program

Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA's Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.

10 Apr 2012

Poor mental health can lead to heart problems and death in dialysis patients

Dialysis patients whose mental health deteriorates over time have an increased risk of developing heart problems and dying prematurely, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

6 Apr 2012

Majority of female kidney failure patients on dialysis may experience sexual problems

The vast majority of female kidney failure patients on dialysis may experience sexual problems, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Additional studies are needed to understand how sexual dysfunction affects dialysis patients' quality of life and psychological wellbeing.

6 Apr 2012

Akebia completes AKB-6548 Phase 2 study for anemia in CKD patients

Akebia Therapeutics, Inc., a pharmaceutical discovery and development company focused on anemia and vascular disorders, today announced that it has successfully completed a randomized, double-blinded, placebo-controlled Phase 2 dose-ranging study of AKB-6548 in patients with stage 3 and 4 chronic kidney disease (CKD).

6 Apr 2012

Hypertensive dialysis patient survives 17 years on the waiting list for a new kidney

Jimmie Jones of Calumet Park, Ill., has beaten all odds to survive 17 years on the waiting list for a new kidney.

5 Apr 2012

ASN participates in ABIM Foundation's Choosing Wisely campaign

The American Society of Nephrology (ASN), the world's leading kidney organization, joins the American Board of Internal Medicine (ABIM) Foundation, eight other leading national medical specialty societies, and Consumer Reports in the new Choosing Wisely campaign that helps health care professionals and patients avoid wasteful and sometimes harmful medical interventions.

5 Apr 2012

Nine physician organizations identify specific tests or procedures that may be unnecessary

Nine leading physician specialty societies have identified specific tests or procedures that they say are commonly used but not always necessary in their respective fields. Patient advocates are calling the move a significant step toward improving the quality and safety of health care.

4 Apr 2012

Leicester Kidney Exercise Team shortlisted for BMJ award

A team of researchers from the University of Leicester, Leicester's Hospitals and the University of Loughborough are in the running for a prestigious medical award.

2 Apr 2012

DaVita thanks nearly 1,500 renal social workers during NASW

DaVita Inc., a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today thanks its nearly 1,500 social workers for the value and care they provide to patients and their families.

29 Mar 2012

Althea provides Allena exclusive worldwide rights to broad hyperoxaluria portfolio

Allena Pharmaceuticals, Inc., and Althea Technologies today announced a licensing agreement under which Allena has obtained the exclusive worldwide rights to Althea's broad hyperoxaluria portfolio including product patents, regulatory information and development data related to oxalate degrading enzymes.

29 Mar 2012

FDA approves Omontys - new anemia drug for chronic kidney disease patients

The Food and Drug Administration (FDA) on Tuesday approved a new drug called Omontys (peginesatide). This is expected to oust Amgen Inc.’s from its near monopoly in the roughly $6 billion U.S. anemia treatment market.

28 Mar 2012

First Edition: March 28, 2012

Today's headlines recap yesterday's Supreme Court action related to the constitutionality of the individual mandate and set the scene for day 3 of the oral arguments, which will tackle issues of severalbility and questions about the health law's Medicaid expansion.

28 Mar 2012

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.

26 Mar 2012

Research roundup: Unequal 'culture of quality' in hospitals; Peer-support for stressed doctors

Comparison Of Hospital Performance In Trauma Vs Emergency And Elective General Surgery –This study compared outcomes of trauma patients and patients having either elective or emergency surgery in the same hospital. Researchers thought that "hospital performance reflected institutional culture, and, thus, would be similar across all services."

23 Mar 2012

New rule ensuring equal access for ESRD patients receives DPC praise

Dialysis Patient Citizens (DPC), the nation's largest patient-led organization representing dialysis patients, applauded the Administration for taking steps to solidify a key provision that will ensure end stage renal disease (ESRD) patients have equal access to private coverage as Affordable Care Act reforms are implemented.

14 Mar 2012

Living-donor parathyroid gland transplant allows young woman to forgo 60 pills per day

Surgeons at the University of Illinois Hospital & Health Sciences System performed a rare living-donor parathyroid gland transplant to help a 22-year-old woman maintain normal calcium levels without the need for high-dose supplementation.

13 Mar 2012

Hospitals with infection control certification may have lower MRSA BSI rates

Hospitals whose infection prevention and control programs are led by a director who is board certified in infection prevention and control have significantly lower rates of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) than those that are not led by a certified professional, according to a new study published in the March issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

12 Mar 2012

Dialysis News and Research

Latest Dialysis News and Research

DaVita introduces Kidney Smart website for patients with CKD

FDA selects three renal device projects for new Pathway program

FDA approval of OMONTYS triggers $50M milestone payment to Affymax

Three ESRD products chosen for FDA's Innovation Pathway program

Poor mental health can lead to heart problems and death in dialysis patients

Majority of female kidney failure patients on dialysis may experience sexual problems

Akebia completes AKB-6548 Phase 2 study for anemia in CKD patients

Hypertensive dialysis patient survives 17 years on the waiting list for a new kidney

ASN participates in ABIM Foundation's Choosing Wisely campaign

Nine physician organizations identify specific tests or procedures that may be unnecessary

Leicester Kidney Exercise Team shortlisted for BMJ award

DaVita thanks nearly 1,500 renal social workers during NASW

Althea provides Allena exclusive worldwide rights to broad hyperoxaluria portfolio

FDA approves Omontys - new anemia drug for chronic kidney disease patients

First Edition: March 28, 2012

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Research roundup: Unequal 'culture of quality' in hospitals; Peer-support for stressed doctors

New rule ensuring equal access for ESRD patients receives DPC praise

Living-donor parathyroid gland transplant allows young woman to forgo 60 pills per day

Hospitals with infection control certification may have lower MRSA BSI rates

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in